Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.

Both Gliadel wafers [1,3-bis(2-chloroethyl)-1-nitrosourea] and temozolomide (TEMO) have been shown in independent studies to prolong survival of patients with recurrent malignant glioma following surgery and radiotherapy. On the basis of preclinical evidence of synergism between Gliadel wafers and T...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gururangan, S., Cokgor, L., Rich, J. N., Edwards, S., Affronti, M. L., Quinn, J. A., Herndon, J. E., Provenzale, J. M., McLendon, R. E., Tourt-Uhlig, S., Sampson, J. H., Stafford-Fox, V., Zaknoen, S., Early, M., Friedman, A. H., Friedman, H. S.
Format: Artigo
Langue:Inglês
Publié: 2001
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1920622/
https://ncbi.nlm.nih.gov/pubmed/11584894
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires